PLUS THERAPEUTICS Files 8-K
Ticker: PSTV · Form: 8-K · Filed: Apr 8, 2026 · CIK: 0001095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
PLUS THERAPEUTICS filed an 8-K, likely routine updates. Check exhibits for details.
AI Summary
On April 8, 2026, PLUS THERAPEUTICS, INC. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates that PLUS THERAPEUTICS, INC. has submitted a standard regulatory report to the SEC, which may contain updates or disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events or financial distress.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Filer of the 8-K report
- 0001095981 (company) — CIK number for PLUS THERAPEUTICS, INC.
- 2026-04-08 (date) — Period of Report and Filing Date
FAQ
What specific events are detailed under Item 8.01 of the filing?
The provided excerpt states Item 8.01 pertains to 'Other Events,' but does not specify what those events are.
What financial statements or exhibits are included in the filing?
The filing includes Item 9.01, covering 'Financial Statements and Exhibits,' with specific documents like an 8-K in iXBRL format and an exhibit EX-99.1 listed.
What is the mailing address of PLUS THERAPEUTICS, INC.?
The mailing address is 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756.
What is the CIK number for PLUS THERAPEUTICS, INC.?
The CIK number for PLUS THERAPEUTICS, INC. is 0001095981.
What is the primary business classification for PLUS THERAPEUTICS, INC. according to the SIC code?
The SIC code 3841 indicates the company is in 'Surgical & Medical Instruments & Apparatus'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2026 regarding PLUS THERAPEUTICS, INC. (PSTV).